TNT-119 is under clinical development by Eliem Therapeutics and currently in Pha...
IL13R alpha 2 CAR-T is under clinical development by TCR Cure Biopharma Technolo...
With patients taking control over health, experts discuss how different players ...
J&J has gained access to several bispecific antibody programmes, including the P...
The US Senator took another swipe at the US prices of Novo Nordisk’s blockbuster...
Erasca has made operational cuts while licensing a molecular glue therapy and a ...
Galapagos has signed a partnership with Blood Centers of America to expedite dec...
The US FDA has granted breakthrough therapy designation (BTD) for Nuvalent’s NVL...
CinDome Pharma has secured $40m in a Series B financing extension round to devel...
LUNA-18 is under clinical development by Chugai Pharmaceutical and currently in ...
LZ-901 is under clinical development by Beijing Luzhu Biotechnology and currentl...
MRNA-1365 is under clinical development by Moderna and currently in Phase I for ...
LY-3541860 is under clinical development by Eli Lilly and Co and currently in Ph...
TT-01488 is under clinical development by TransThera Sciences (Nanjing) and curr...
Influenza (quadrivalent) vaccine is under clinical development by Pfizer and cur...
Opzelura is under clinical development by Incyte and currently in Phase II for G...
